Cargando…
Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update
BACKGROUND: Chronic liver disease and cirrhosis are a leading cause of morbidity and mortality in the United States. Primary biliary cholangitis (PBC), previously known as primary biliary cirrhosis and which has been designated an orphan condition, is a chronic autoimmune disease resulting in the de...
Autores principales: | Bowlus, Christopher L., Kenney, James T., Rice, Gary, Navarro, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408407/ https://www.ncbi.nlm.nih.gov/pubmed/27700211 http://dx.doi.org/10.18553/jmcp.2016.22.10-a-s.s3 |
Ejemplares similares
-
Blurring Lines of Medical and Pharmacy Management: The New Role of Specialty Pharmaceuticals
por: Sullivan, Sean D., et al.
Publicado: (2008) -
Meeting Abstracts - AMCP Managed Care & Specialty Pharmacy Annual Meeting 2018
Publicado: (2018) -
Asthma Management Guidelines: Updates, Advances, and New Options
por: Navarro, Robert P., et al.
Publicado: (2007) -
Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection
por: Bowlus, Christopher L
Publicado: (2016) -
A real‐world observational cohort of patients with primary biliary cholangitis: TARGET‐primary biliary cholangitis study design and rationale
por: Levy, Cynthia, et al.
Publicado: (2018)